Let do the math...
COVID-19 revenue = 10-20
Let do the math...
COVID-19 revenue = 10-20 billion
HIV duel revenue = 5 billion
MTNBC revenue = 60 billion
For argument sake let’s call it low at 75 billion revenue predicted in 2021
We have a total of 4 possible FDA approvals this year to make that happen.
1) COVID-19 mild to moderate
2) COVID-19 severe
3) HIV Duel therapy
4) MTNBC...
All could happen in the next couple of months. Or before the end of the year. What’s our stock worth at 75 billion projected income for 2021?
Hers and Hers2 breast cancer is worth 15 billion in current market and MTNBC Has 4 times the potential revenue and is really doing well with both Hers and Hers2 also. So might be more market share in Breast cancer than just mTNBC. What about the Basket trial for the other 21 cancers? Is that a early next year approval or late next year?
Do you think that same mechanism of action can be proved by mTNBC trials and the other Cancer indications In trial now just by mechanism of action? Do we see this as a long trial? With cancer approvals this company rockets
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...
Continue Reading
Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...
Continue Reading
Unifying Molecular Diagnostics for Better Cancer Care In the chaos of today’s healthcare, Aranscia is aiming to rewrite the book on how we handle cancer diagnostics by teaming up with Northside Hospital Cancer Institute. Now, instead of fumbling through disconnected systems, they plan to glue the pieces together with a blend of their own and borrowed tech. This...
Continue Reading
Bringing New Leadership to Charter Next Generation It's an intriguing time to be watching Charter Next Generation (CNG) as they just added a heavyweight to their executive team. Todd Herndon, a veteran with more than three decades of financial savvy, steps in as their new Chief Financial Officer. This is like a football team drafting a star quarterback right before the...
Continue Reading
AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...
Continue Reading
When it comes to honoring legacy and future within the Black beauty industry, the 2026 Beauty Icon Awards seem ready to steal the spotlight. Set to take place on October 10th at Atlanta's Riverside EpiCenter, this gathering is more than just a fancy shindig – it's a tribute to Black beauty's massive influence on culture and commerce. Celebrating Pioneers and Innovators...
Continue Reading
A Fresh Chapter for Half Moon Cay Mark it down, folks—Holland America Line is shaking things up over at RelaxAway, Half Moon Cay. The cruise line, known for its deep roots in premium cruising, is pouring resources into its private island playground to celebrate its 30th anniversary in 2027. And the timing couldn't be more calculated, what with peak cruise season around...
Continue Reading
A Fresh Start for Young Careers with CareerPath You remember the time in life when we thought just having a degree meant something? Well, the game’s changed, and now it’s a twisted jungle where young folks struggle to find their footing. Partners International, a name I’m no stranger to—known for their human capital wizardry—seems to have noticed this chaotic...
Continue Reading
A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...
Continue Reading
Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...
Continue Reading
Top 5 Most Recently Viewed Articles
Rilzabrutinib Granted Orphan Drug Designation Rilzabrutinib, an innovative medication, has received orphan drug designation from the US Food and Drug Administration (FDA) for treating two rare diseases: warm autoimmune hemolytic anemia (wAIHA) and IgG4-related disease (IgG4-RD). This designation acknowledges the significant unmet medical need faced by patients affected by...
Continue Reading
Elliott Hill Takes the Helm as NIKE, Inc. CEO NIKE, Inc. (NYSE:NKE) recently made waves with the announcement that Elliott Hill will step into the role of President and Chief Executive Officer. This important shift signals a notable change for the renowned sports brand, as Hill's leadership is anticipated to steer the company into a new phase of growth and innovation. A...
Continue Reading
Understanding Today's CPI Data Release Today marks an important moment for the financial markets as the US releases its Consumer Price Index (CPI) data. Investors and analysts are keenly observing the inflation figures for any signs of trends that could influence market decisions. The spotlight is on the projected 0.3% increase in headline inflation, which would maintain...
Continue Reading
BioArctic's Key Contributions to Alzheimer's Research Unveiled At the upcoming Clinical Trials for Alzheimer's Disease Conference (CTAD), held from late October to early November, the spotlight will shine brightly on the groundbreaking efforts of BioArctic AB's founder Lars Lannfelt. He is set to receive the Lifetime Achievement Award for his extensive contributions to...
Continue Reading
Exploring the Pet Grooming Services Market Growth The pet grooming services market is witnessing a remarkable transformation, with anticipated growth projected to reach over USD 12.05 billion during the next decade. The rising phenomenon of pet ownership, coupled with the ongoing trend of humanization, is significantly influencing this expansion. The global market was...
Continue Reading